Cefpodoxime proxetil is an orally active, broad spectrum, third generation cephalosporin ester, This prodrug was previously found to be hydrolyzed in vitro both in rabbit and human duodenal washing by a cholinesterase. The objective of this work was to find a formulation which can protect the prodrug: from enzymatic attack. In order to protect the prodrug from enzymatic hydrolysis, the objective was to include it into the oil phase of an oil-in-water (o/w) emulsion. Somehow, cefpodoxime proxetil posed specific problems related to the solubilization. The solubilization was obtained with a mixed medium-chain-triglycerides (MCT)/blends of mono-, di-and triglycerides oil phase and the optimal ratio was defined to be 60:40 (w/w) in order to obtain emulsification. The emulsifier was a soybean lecithin alone or in mixtures with polysorbate 20. This non-ionic surfactant was chosen since it was found to directly inhibit the hydrolysis of cefpodoxime proxetil in vitro using duodenal washings. The o/w submicron emulsions were proven to be effective in protecting the prodrug from enzymatic attack in rabbit duodenal washings compared with a micellar solution and an aqueous solution of cefpodoxime proxetil. An o/w submicron emulsion incorporating polysorbate 20 was found to be the most protective, which can corroborate the inhibitory role of polysorbate itself. (C) 1998 Elsevier Science B.V. All rights reserved.